Perioperative ADministration of Dexamethasone And blood Glucose concentrations in patients undergoing elective non-cardiac surgery - the randomised controlled PADDAG trial

被引:23
|
作者
Corcoran, Tomas B. [1 ,2 ]
O'Loughlin, Edmond [1 ,3 ]
Chan, Matthew T. V. [4 ]
Ho, Kwok M. [5 ,6 ,7 ]
机构
[1] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp TBC, Dept Anaesthesia & Pain Med, Perth, WA, Australia
[2] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
[3] Fiona Stanley Hosp, Dept Anaesthesia & Pain Med, Perth, WA, Australia
[4] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Shatin, Hong Kong, Peoples R China
[5] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia
[6] Univ Western Australia, Med Sch, Perth, WA, Australia
[7] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia
关键词
POSTOPERATIVE NAUSEA; VOMITING PROPHYLAXIS; DOSE DEXAMETHASONE; CARDIAC-SURGERY; GLUCOCORTICOIDS; HYPERGLYCEMIA;
D O I
10.1097/EJA.0000000000001294
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND The hyperglycaemic effect of dexamethasone in diabetic and nondiabetic patients in the peri-operative period is unknown. OBJECTIVE To assess the effect of a single dose of intra-operative dexamethasone on peri-operative blood glucose. DESIGN Multicentre, stratified, randomised trial. SETTING University hospitals in Australia and Hong Kong. PATIENTS A total of 302 adults scheduled for elective, noncardiac and nonobstetric surgical procedures under general anaesthesia, stratified by diabetes mellitus status, were randomised to receive placebo, 4 or 8 mg dexamethasone administered intravenously after induction of anaesthesia. MAIN OUTCOME MEASURES Maximum blood glucose within 24 h of surgery, and the interaction between glycated haemoglobin (HbA1c) and dexamethasone were the primary and secondary outcomes. RESULTS The median [IQR] baseline blood glucose in the nondiabetes stratum in the placebo (n=81), 4 mg (n=81) and 8 mg dexamethasone (n=77) trial arms were respectively 5.3 [4.6 to 5.8], 5.0 [4.7 to 5.4] and 5.0 [4.2 to 5.9] mmol l(-1). In the diabetes stratum these values were 6.6 [6.0 to 8.3]; (n=22), 6.1 [5.5 to 10.4]; (n=22) and 6.7 [5.6 to 8.3]; (n=19) mmol l(-1). The median [IQR] maximum peri-operative blood glucose values in the nondiabetes stratum were 6.0 [5.3 to 6.8], 6.3 [5.5 to 7.3] and 6.3 [5.8 to 7.4] mmol l(-1) in the control, dexamethasone 4 mg and dexamethasone 8 mg arms, respectively. In the diabetes stratum these values were 10.3 [8.1 to 12.4], 12.6 [10.3 to 18.3] and 13.6 [11.2 to 20.1] mmol l(-1). There was a significant interaction between pre-operative HbA1c value and 8 mg dexamethasone: every 1% increment in HbA1c produced a 4.0 mmol l(-1) elevation in maximal peri-operative glucose concentration. CONCLUSION Dexamethasone 4 mg or 8 mg did not induce greater hyperglycaemia compared with placebo for nondiabetic and well controlled diabetic patients. Maximal peri-operative blood glucose concentrations in patients with diabetes were related to baseline HbA1c values in a concentration-dependent fashion after 8 mg of dexamethasone.
引用
收藏
页码:932 / 942
页数:11
相关论文
共 50 条
  • [31] Calcium administration In patients undergoing CardiAc suRgery under cardiopulmonary bypasS (ICARUS trial): Rationale and design of a randomized controlled trial
    Lomivorotov, Vladimir
    Ponomarev, Dmitry
    Boboshko, Vladimir
    Shmyrev, Vladimir
    Ismoilov, Samandar
    Efremov, Sergey
    Kamenshchikov, Nikolay
    Akselrod, Boris
    Pasyuga, Vadim
    Urusov, Dmitry
    Ovezov, Alexey
    Evdokimov, Mikhail
    Turchaninov, Alexander
    Bogachev-Prokofiev, Alexander
    Bukamal, Nazar
    Afifi, Sarah
    Belletti, Alessandro
    Bellomo, Rinaldo
    Landoni, Giovanni
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 23
  • [32] Conventional versus minimally invasive extracorporeal circulation in patients undergoing cardiac surgery: protocol for a randomised controlled trial (COMICS)
    Angelini, Gianni D.
    Reeves, Barnaby C.
    Evans, Jonathan
    Culliford, Lucy A.
    Collett, Laura
    Rogers, Chris A.
    Stokes, Elizabeth
    Anastasiadis, Kyriakos
    Antonitsis, Polychronis
    Carrel, Thierry
    Keller, Dorothee
    Liebold, Andreas
    Ashkanani, Fatma
    El-Essawi, Aschraf
    Breitenbach, Ingo
    Lloyd, Clinton
    Bennett, Mark
    Cale, Alex
    Mclean, Lindsay
    Gunaydin, Serdar
    Gunertem, Eren
    Oueida, Farouk
    Yassin, Ibrahim
    Serrick, Cyril
    Rao, Vivek
    Moscarelli, Marco
    Condello, Ignazzo
    Punjabi, Prakash
    Rajakaruna, Cha
    Bone, Daniel
    Lansdown, William
    Moorjani, Narain
    Dennis, Sarah
    PERFUSION-UK, 2021, 36 (04): : 388 - 394
  • [33] Effects of subanaesthetic S-ketamine on postoperative delirium and cognitive function in elderly patients undergoing non-cardiac thoracic surgery: a protocol for a randomised, double-blinded, placebo-controlled and positive-controlled, non-inferiority trial (SKED trial)
    Wei, Wei
    Zhang, Anyu
    Liu, Lv
    Zheng, Xi
    Tang, Chunlin
    Zhou, Ming
    Gu, Yu
    Yao, Yonghua
    BMJ OPEN, 2022, 12 (08):
  • [34] Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: A randomised trial
    Leong, Jee-Yoong
    van der Merwe, Juliana
    Pepe, Salvatore
    Bailey, Michael
    Perkins, Anthony
    Lymbury, Robyn
    Esmore, Donald
    Marasco, Silvana
    Rosenfeldt, Franklin
    HEART LUNG AND CIRCULATION, 2010, 19 (10) : 584 - 591
  • [35] Prophylactic cryoprecipitate transfusion in patients undergoing scoliosis surgery: A randomised-controlled trial
    Ismail, Tarek I.
    Mahrous, Rabab S. S.
    JOURNAL OF PERIOPERATIVE PRACTICE, 2024, 34 (03) : 60 - 69
  • [36] Extract from the 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery - Patient Blood Management
    Halvorsen, Sigrun
    Mehilli, Julinda
    Choorapoikayil, Suma
    Zacharowski, Kai
    BLOOD TRANSFUSION, 2024, 22 (02) : 122 - 129
  • [37] Comparative study between insulin bolus regimen and glucose insulin infusion regimen on effectiveness of intraoperative blood glucose control in patients with type 2 diabetes mellitus undergoing non-cardiac surgery
    Arun, Parthasarathy
    Krishna, Handattu Mahabaleswara
    SRI LANKAN JOURNAL OF ANAESTHESIOLOGY, 2019, 27 (02): : 110 - 114
  • [38] Individualised or liberal red blood cell transfusion after cardiac surgery: a randomised controlled trial
    Fischer, Marc-Olivier
    Guinot, Pierre-Gregoire
    Debroczi, Stephane
    Huette, Pierre
    Beyls, Christophe
    Babatasi, Gerard
    Bafi, Kevin
    Guilbart, Mathieu
    Caus, Thierry
    Lorne, Emmanuel
    Dupont, Herve
    Hanouz, Jean-Luc
    Diouf, Momar
    Abou-Arab, Osama
    BRITISH JOURNAL OF ANAESTHESIA, 2022, 128 (01) : 37 - 44
  • [39] Perioperative outcome, long-term mortality and time trends in elderly patients undergoing low-, intermediate- or major non-cardiac surgery
    Tjeertes, E. K. M.
    Simoncelli, T. F. W.
    van den Enden, A. J. M.
    Mattace-Raso, F. U. S.
    Stolker, R. J.
    Hoeks, S. E.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 (01)
  • [40] Effect of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: A single-blind, randomized controlled trial
    Lips, Michal
    Mraz, Milos
    Klouckova, Jana
    Kopecky, Petr
    Dobias, Milos
    Krizova, Jarmila
    Lindner, Jaroslav
    Diamant, Michaela
    Haluzik, Martin
    DIABETES OBESITY & METABOLISM, 2017, 19 (12) : 1818 - 1822